MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 05-23-2026
Genetic Technologies Limited Cash Conversion Cycle 2011-2026 | GENE
Annual Cash Conversion Cycle Genetic Technologies Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 11 K | 1.18 | 61.8 | 168 | 48 | -47.6 | -41.1 | 46.1 | -187 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11 K | -187 | 1.23 K |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 201.02 | -1.01 % | $ 22.3 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 3.93 | -8.39 % | $ 5.23 M | USA |
 |
Fulgent Genetics
FLGT
|
51.8 | $ 18.54 | -0.75 % | $ 571 M | USA |
 |
Castle Biosciences
CSTL
|
31.6 | $ 20.56 | -0.68 % | $ 596 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 1.65 | 3.12 % | $ 7.3 M | USA |
 |
Illumina
ILMN
|
147 | $ 164.39 | 2.12 % | $ 25.5 B | USA |
 |
Guardant Health
GH
|
79.6 | $ 129.45 | -1.65 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.98 | 0.04 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
52.5 | $ 146.18 | - | $ 11.5 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
NeoGenomics
NEO
|
82.4 | $ 11.09 | -0.54 % | $ 1.42 B | USA |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
29.4 | $ 18.35 | -2.34 % | $ 411 M | USA |
 |
Natera
NTRA
|
48.3 | $ 214.4 | 1.1 % | $ 29.3 B | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 103.97 | -0.53 % | $ 7.02 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 189.74 | 1.19 % | $ 9.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.37 | 4.2 % | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 467.9 | 0.12 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 142.32 | 0.96 % | $ 23.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.29 | -0.92 % | $ 397 M | USA |
 |
Personalis
PSNL
|
-1.89 | $ 9.8 | 2.19 % | $ 875 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.83 | 1.4 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
36.1 | $ 7.28 | 1.35 % | $ 304 M | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 79.83 | 4.81 % | $ 4.77 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.03 | -1.22 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 263.98 | -0.82 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 469.74 | 0.19 % | $ 177 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.64 | -1.51 % | $ 230 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
150 | $ 9.13 | 0.33 % | $ 1.98 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |